Daiichi Sankyo RD Novare Co., Ltd., 1-16-13 Kitakasai, Edogawa-ku, Tokyo 134-8630, Japan.
Daiichi Sankyo RD Novare Co., Ltd., 1-16-13 Kitakasai, Edogawa-ku, Tokyo 134-8630, Japan.
Bioorg Med Chem Lett. 2021 Jun 15;42:128093. doi: 10.1016/j.bmcl.2021.128093. Epub 2021 May 6.
Novel cyclic peptide derivatives based on ogipeptins A, B, C, and D were synthesized. Starting with a mixture of ogipeptins A-D, a practical four-step synthetic procedure was followed to prepare novel derivatives with various kinds of acyl side chains. Among the 45 new synthetic derivatives identified, the antibacterial activities of compounds 8-3 and 8-38 were comparable with those of ogipeptin A. In in vitro nephrotoxicity screening using LLC-PK1 cells, compounds 8-3 and 8-38 showed significantly lower cytotoxicity (LD > 480 μM) than colistin (LD = 44.2 μM).
基于奥肽菌素 A、B、C 和 D,我们合成了新型环肽衍生物。以奥肽菌素 A-D 的混合物为起始原料,通过实用的四步合成方法,制备了具有各种酰基侧链的新型衍生物。在所鉴定的 45 种新型合成衍生物中,化合物 8-3 和 8-38 的抗菌活性与奥肽菌素 A 相当。在使用 LLC-PK1 细胞进行的体外肾毒性筛选中,化合物 8-3 和 8-38 的细胞毒性(LD>480μM)明显低于粘菌素(LD=44.2μM)。